Managers' transactions announcement according to article 19 MAR
Leverkusen, Germany (pta025/25.11.2022/14:04) - Announcement
| 1 | Details of the person discharging managerial responsibilities/person closely associated | |
| a) | Name | Deutsche Balaton Biotech AG |
| 2 | Reason for the notification | |
| a) | Position/status | Person closely associated |
| Mr. Wilhelm K. T. Zours | ||
| Member of the administrative or supervisory body | ||
| b) | Initial notification | |
| 3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |
| a) | Name | Biofrontera AG |
| b) | LEI | 391200D6GFSVFGFQTL13 |
| 4 | Details of the transaction(s) | |
| a) | Description of the financial instrument, type of instrument | Share |
| Identification code | DE0006046113 | |
| b) | Nature of the transaction | Another |
| Acquisition of shares through exercise of subscription rights | ||
| c) | Price(s) | Volume(s) |
| 1.00 EUR | 296,548.00 EUR | |
| d) | Aggregated price | Aggregated volume |
| 1.00 EUR | 296,548.00 EUR | |
| e) | Date of the transaction | 23.11.2022 UTC+1 |
| f) | Place of the transaction | Outside a trading venue |
(end)
emitter: Biofrontera AG
address: Hemmelrather Weg 201, 51377 Leverkusen
country: Germany
contact person: Investor Relations
phone: +49 (0) 214 87 63 20
e-mail: ir@biofrontera.com
website: www.biofrontera.com
ISIN(s): DE0006046113 (share)
stock exchanges: regulated market in Frankfurt, Dusseldorf; free market in Stuttgart, free market in Munich; open market in Berlin, Tradegate